Fingerprint
Dive into the research topics of 'Low-dose solumatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, phase III safety study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Low-dose solumatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, phase III safety study
Roy D. Altman, Vibeke Strand, Marc C. Hochberg, Allan Gibofsky, Joseph A. Markenson, William E. Hopkins, Byron Cryer, Alan Kivitz, Jennifer Nezzer, Olaolu Imasogie, Clarence L. Young
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations